Literature DB >> 2966250

Mortality and survival of the Down's syndrome population in Western Australia.

Q Malone1.   

Abstract

From 1976 to 1984, there were 149 Down's syndrome live births in Western Australia. Where previously the coexistence of congenital heart disease was a major determinant of early mortality, current survival rates do not reflect this. Survival rates have significantly increased over the last decade: particularly so for those with coexistent congenital heart disease. Projected frequencies for Down's syndrome persons in Western Australia are expected to significantly increase. This rise in prevalence will have major economic effects on the planning and delivery of health care for this population.

Entities:  

Mesh:

Year:  1988        PMID: 2966250     DOI: 10.1111/j.1365-2788.1988.tb01388.x

Source DB:  PubMed          Journal:  J Ment Defic Res        ISSN: 0022-264X


  5 in total

1.  Childhood deaths in Down's syndrome. Survival curves and causes of death from a total population study in Queensland, Australia, 1976 to 1985.

Authors:  J A Bell; J H Pearn; D Firman
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

2.  The population prevalence of Down's syndrome in England and Wales in 2011.

Authors:  Jianhua Wu; Joan K Morris
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

3.  Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.

Authors:  Benjamin L Handen; Ann D Cohen; Umapathy Channamalappa; Peter Bulova; Sheila A Cannon; William I Cohen; Chester A Mathis; Julie C Price; William E Klunk
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

Review 4.  Amyloid PET imaging: applications beyond Alzheimer's disease.

Authors:  Ana M Catafau; Santiago Bullich
Journal:  Clin Transl Imaging       Date:  2015-01-21

5.  Aging and bone health in individuals with developmental disabilities.

Authors:  Joan Jasien; Caitlin M Daimon; Stuart Maudsley; Bruce K Shapiro; Bronwen Martin
Journal:  Int J Endocrinol       Date:  2012-07-22       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.